On Cancer: Targeted Therapy

and/or

85 Blog posts found

Q&A

What’s Behind the Rise in Liver Cancer Deaths — and What Can Be Done About It?

Find out what’s contributing to a marked increase in the death rate for liver cancer.

Illustration of liver inside human torso with other organs (intestines) also visible.

Feature

What Really Matters in Treating Brain Cancer: An Interview with Two MSK Experts

Two of MSK's top brain experts reflect on how they care for people and recent advances in treatment.

Viviane Tabar and Lisa DeAngelis

Feature

The Treatments Changing Childhood Cancer: At Work with Filemon Dela Cruz

Go behind the scenes with Filemon Dela Cruz, who cares for children with sarcoma and conducts precision medicine research at Memorial Sloan Kettering.

MSK pediatric oncologist Filemon Dela Cruz

In the Clinic

Taking on Mantle Cell Lymphoma: MSK Leads Research into New Treatments

Learn about novel therapies emerging for the treatment of mantle cell lymphoma.

MSK medical oncologist Anita Kumar

In the Clinic

How Acute Myeloid Leukemia Is Treated at MSK: An Interview with Martin Tallman

Learn about the latest advances in treatment for AML and how people can benefit from receiving their treatment at MSK.

Leukemia Service Chief Martin Tallman

Finding

Study Suggests More People with Kidney Cancer Should Be Screened for Hereditary Cancer Genes

Researchers have found that more than 20% of people with a type of cancer called advanced non-clear cell renal cell carcinoma have disease that is driven by inherited cancer mutations.

Papillary renal cell carcinoma under the microscope

Announcement

FDA Approves Ivosidenib (Tibsovo®), a Targeted Drug, for Acute Myeloid Leukemia

The drug provides a new treatment option for people whose cancer has stopped responding to other therapies.

Hematologic oncologist Martin Tallman and nurse practitioner Bernadette Cuello

In the Lab

Splicing May Be an Effective Target in the Fight against Cancer

New drugs are being developed that target part of the process to make proteins.

MSK physician-scientist Omar Abdel-Wahab

Finding

Findings from Two Patients Shed New Light on Drug Resistance in AML

A team at MSK has discovered a previously unknown type of resistance to a new leukemia drug.

Leukemia cells